Insights into the Molecular Mechanism of Endothelial Glycocalyx Dysfunction during Heart Surgery

Antea Kršek,Lara Batičić,Božena Ćurko-Cofek,Tanja Batinac,Gordana Laškarin,Silvija Miletić-Gršković,Vlatka Sotošek
DOI: https://doi.org/10.3390/cimb46050236
2024-04-23
Current Issues in Molecular Biology
Abstract:The endothelial glycocalyx (EGC) is a layer of proteoglycans (associated with glycosaminoglycans) and glycoproteins, which adsorbs plasma proteins on the luminal surface of endothelial cells. Its main function is to participate in separating the circulating blood from the inner layers of the vessels and the surrounding tissues. Physiologically, the EGC stimulates mechanotransduction, the endothelial charge, thrombocyte adhesion, leukocyte tissue recruitment, and molecule extravasation. Hence, severe impairment of the EGC has been implicated in various pathological conditions, including sepsis, diabetes, chronic kidney disease, inflammatory disorders, hypernatremia, hypervolemia, atherosclerosis, and ischemia/reperfusion injury. Moreover, alterations in EGC have been associated with altered responses to therapeutic interventions in conditions such as cardiovascular diseases. Investigation into the function of the glycocalyx has expanded knowledge about vascular disorders and indicated the need to consider new approaches in the treatment of severe endothelial dysfunction. This review aims to present the current understanding of the molecular mechanisms underlying cardiovascular diseases and to elucidate the impact of heart surgery on EGC dysfunction.
biochemistry & molecular biology
What problem does this paper attempt to address?
The paper aims to explore the molecular mechanisms of endothelial glycocalyx (EGC) dysfunction during cardiac surgery. The endothelial glycocalyx is a layer composed of proteoglycans (associated with glycosaminoglycans) and glycoproteins, whose main function is to separate the blood from the internal and surrounding tissues of the blood vessels. Its physiological functions include participating in mechanotransduction, regulating endothelial charge, platelet adhesion, leukocyte recruitment, and molecular extravasation. EGC damage is associated with various pathological conditions such as sepsis, diabetes, chronic kidney disease, inflammatory diseases, hypernatremia, volume overload, atherosclerosis, and ischemia/reperfusion injury. Additionally, changes in EGC can affect therapeutic responses in cardiovascular diseases. The focus of the paper is to reveal the molecular mechanisms of EGC dysfunction during cardiac surgery and to explore the impact of these mechanisms on cardiovascular health. By understanding these mechanisms, a theoretical basis can be provided for new treatments for severe endothelial dysfunction. Specifically, the paper discusses the structural changes of EGC during cardiac surgery and their effects on blood flow, inflammatory response, and endothelial cell function.